Protein kinases are central to regulation of cellular signaling in the eukaryotes. Wellconserved and lineage-specific protein kinases have previously been identified from various completely sequenced genomes of eukaryotes. The current work describes a genome-wide analysis for protein kinases encoded in the Plasmodium falciparum genome. Using a few different profile matching methods, we have identified 99 protein kinases or related proteins in the parasite genome. We have classified these kinases into subfamilies and analyzed them in the context of noncatalytic domains that occur in these catalytic kinase domain-containing proteins.
Cyclic nucleotides are well-known second messengers involved in the regulation of
important metabolic pathways or virulence factors. There are six different classes
of nucleotide cyclases that can accomplish the task of generating cAMP, and four
of these are restricted to the prokaryotes. The role of cAMP has been implicated in
the virulence and regulation of secondary metabolites in the phylum Actinobacteria, which contains
important pathogens, such as Mycobacterium tuberculosis, M. leprae, M. bovis
and Corynebacterium, and industrial organisms from the genus Streptomyces.
We have analysed the actinobacterial genome sequences found in current databases
for the presence of different classes of nucleotide cyclases, and find that only class
III cyclases are present in these organisms. Importantly, prominent members such as
M. tuberculosis and M. leprae have 17 and 4 class III cyclases, respectively, encoded
in their genomes, some of which display interesting domain fusions seen for the
first time. In addition, a pseudogene corresponding to a cyclase from M. avium has
been identified as the only cyclase pseudogene in M. tuberculosis and M. bovis. The
Corynebacterium and Streptomyces genomes encode only a single adenylyl cyclase
each, both of which have corresponding orthologues in M. tuberculosis. A clustering
of the cyclase domains in Actinobacteria reveals the presence of typical eukaryote-like,
fungi-like and other bacteria-like class III cyclase sequences within this phylum,
suggesting that these proteins may have significant roles to play in this important
group of organisms.
Phosphorylation of the mycobacterial transcriptional activator, EmbR, is essential for transcriptional regulation of the embCAB operon encoding cell wall arabinosyltransferases. This signaling pathway eventually affects the resistance to ethambutol (a frontline antimycobacterial drug) and the cell wall Lipoarabinomannan/Lipomannan ratio (an important determinant for averting the host immune response). In this study, further biochemical characterization revealed that EmbR, as a transcriptional regulator, interacts with RNA polymerase and possesses a phosphorylation‐dependent ATPase activity that might play a role in forming an open complex between EmbR and RNA polymerase. EmbR was recently shown to be phosphorylated by the cognate mycobacterial serine/threonine (Ser/Thr) kinase, PknH. Using bioinformatic analysis and in vitro assays, we identified additional novel regulators of the signaling pathway leading to EmbR phosphorylation, namely the Ser/Thr protein kinases PknA and PknB. A previously unresolved question raised by this signaling scheme is the fate of phosphorylated kinases and EmbR at the end of the signaling cycle. Here we show that Mstp, a mycobacterial Ser/Thr phosphatase, antagonizes Ser/Thr protein kinase–EmbR signaling by dephosphorylating Ser/Thr protein kinases, as well as EmbR, in vitro. Additionally, dephosphorylation of EmbR reduced its ATPase activity, interaction with Ser/Thr protein kinases and DNA‐binding activity, emphasizing the antagonistic role of Mstp in the EmbR–Ser/Thr protein kinase signaling system.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.